Sihuan Pharmaceutical Holdings Group Ltd.의 주요 재무제표는 무엇인가요?
SHPHF의 주요 재무 비율은 무엇인가요?
Sihuan Pharmaceutical Holdings Group Ltd.의 매출은 부문 또는 지역별로 어떻게 나뉘나요?
Sihuan Pharmaceutical Holdings Group Ltd.은 수익성이 있나요?
Sihuan Pharmaceutical Holdings Group Ltd.에 부채가 있나요?
Sihuan Pharmaceutical Holdings Group Ltd.의 발행 주식은 몇 주인가요?
주요 통계
이전 종가
$0.17
시가
$0.2103
일일 범위
$0.17 - $0.2103
52주 범위
$0.0492 - $0.235
거래량
1.0K
평균 거래량
1.6K
EPS(TTM)
0.00
배당수익률
--
시가총액
$1.5B
Sihuan Pharmaceutical Holdings 란 무엇인가요?
Sihuan Pharmaceutical Holdings Group Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products. The company is headquartered in Beijing, Beijing and currently employs 2,767 full-time employees. The company went IPO on 2010-10-28. The firm operates its business through three segments. The Medical Aesthetic Products segment includes the filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skin care and others to provide non- or minimally invasive medical aesthetic comprehensive solutions. The Innovative Medicine and Other Medicine segment is engaged in the research and development and commercialization of innovative medicine in the disease fields of diabetes, breast cancer, digestion disorders, oncology and non-alcoholic steatohepatitis and others. The Generic Medicine segment is engaged in the production and sale of generic medicine including Kelin’ao and other products. The firm conducts its business in the domestic and overseas markets.